Juridical Analysis of the Abuse of Kratom Herbal Plants According to Law Number 35 of2009 Concerning Narcotics
DOI:
https://doi.org/10.58344/locus.v4i10.4768Keywords:
Kratom, Psychoactive Effects, Narcotics, Regulation, Indonesian LawAbstract
The development of the use of the herbal plant kratom as an alternative medicine and fulfillment of health needs continues to increase, both at the national and global levels. One of the herbal plants that attracts attention is one of the plants originating from Southeast Asia, including Indonesia, Malaysia, and Thailand (Hassan Z et al. 2013). In Buntok City, South Barito Regency, Central Kalimantan Province, kratom has long been used as part of traditional medicine practices by the local community. UNODC (United Nations Office on Drugs and Crime) in 2013 classified kratom as New Psychoactive Substances, then the Food and Drug Supervisory Agency (BPOM) issued Circular Number in 2016 concerning the Prohibition of the Use of Mitragyna speciosa (kratom) in Traditional Medicine and Food Supplements which was later supported by the National Narcotics Agency. This means that kratom leaves were still not prohibited until 2022. This study aims to analyze the legal status of the herbal plant kratom (Mitragyna speciosa) which has psychoactive effects but has not yet been included in the narcotics category in Indonesia. Kratom has been traditionally used in several regions, but lately it has been misused as a psychoactive substance that causes narcotic-like effects. This study uses a normative juridical approach with qualitative methods, through literature studies, and interviews with legal experts and health practitioners. The results show that kratom has not been specifically regulated in Law Number 35 of 2009 concerning Narcotics, although it has the potential to be misused. The recommendation of this research is to strengthen regulations related to kratom, either through revisions to the narcotics law or the creation of special regulations.
References
Grundmann, O., Hendrickson, R. G., & Greenberg, M. I. (2021). Kratom use in the United States: A review of the literature and observational studies. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 41(3), 256-269. https://doi.org/10.1002/phar.2493
Mukhlisi, M., Widowati, L., & Hadayani, L. (2018). Kratom: Prospek kesehatan dan sosial ekonomi. Badan Penelitian dan Pengembangan Kesehatan.
Singh, D., Narayanan, S., Müller, C. P., Swogger, M. T., Chear, N. J. Y., Dzulkapli, E. B., Yusoff, N. S. M., Ramachandram, D. S., León, F., McCurdy, C. R., Vicknasingam, B. K., & Murugaiyah, V. (2020). Motives for using kratom (Mitragyna speciosa Korth.) among regular users in Malaysia. Journal of Ethnopharmacology, 253, Article 112339. https://doi.org/10.1016/j.jep.2019.112339
United Nations Office on Drugs and Crime. (2017). Kratom (Mitragyna speciosa): Review of scientific information on the use, health effects and regulatory status. https://www.unodc.org/documents/scientific/Kratom.pdf
Ahmad, I., et al. (2022). Mitragyna Species as Pharmacological Agents: From abuse to promising pharmaceutical products. [Artikel terindeks di NCBI PMC].
Dewatisari, W. F., et al. (2025). A Review on Alkaloid Diversity in Mitragyna speciosa: Influence of Strain and Geographic Origin. Journal / Proceeding (versi versi terindeks).
Ni’ma, N. S., et al. (2024). “Kratom (Mitragyna speciosa) : Medicinal Marvel or Menace”. Indonesian Journal of Chemical Science, 13(1).
Ramanathan, S. (2021). Kratom (Mitragyna speciosa Korth.): A description on the botany, ethnobotany, and alkaloid chemistry. Dalam buku The Botany of Kratom.
Buckhalter, S., et al. (2021). The antidepressant-like and analgesic effects of kratom (Mitragyna speciosa). Frontiers in Pharmacology.
Case Report of Kratom-Induced Psychosis. (2021). National Library of Medicine (PMC).
DEA. (2020). Drug Fact Sheet: Kratom. U.S. Drug Enforcement Administration.
Frontiers. (2025). The acute adverse health effects of kratom: An evaluation of case reports. Frontiers in Pharmacology.
Heywood, J., et al. (2024). Beneficial and adverse health effects of kratom (Mitragyna speciosa). Elsevier / ScienceDirect.
Hossain, R., et al. (2023). A critical review of the neuropharmacological effects of kratom. Molecules, 28(12).
Kruegel, A. C., et al. (2019). 7-Hydroxymitragynine is an active metabolite of mitragynine. ACS Central Science.
Todd, D. A., et al. (2020). Chemical composition and biological effects of kratom alkaloids. Journal of Natural Products, 83(1), 216–226.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Dani Kurniadi, Yacob F. Martono, Yurika F Dewi
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
